Real-World Use of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer Following Prior Ado-trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade with Pertuzumab Plus Trastuzumab
07:30am - 03:45pm EDT - March 31, 2023